Get the Stockscreener App
4.18
1.65%
-0.07
Agenus Inc stock is traded at $4.18, with a volume of 317.01K.
It is down -1.65% in the last 24 hours and down -28.91% over the past month.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
See More
Previous Close:
$4.25
Open:
$4.27
24h Volume:
317.01K
Relative Volume:
0.27
Market Cap:
$133.19M
Revenue:
$160.43M
Net Income/Loss:
$-227.64M
P/E Ratio:
-0.0608
EPS:
-68.77
Net Cash Flow:
$-170.79M
1W Performance:
-7.52%
1M Performance:
-28.91%
6M Performance:
+46.15%
1Y Performance:
-16.23%
1-Day Range:
$4.13
$4.29
1-Week Range:
$4.13
$4.70
52-Week Range:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Name
Agenus Inc
Sector
Industry
Phone
781-674-4410
Address
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
4.18 | 135.42M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-19-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-06-23 | Initiated | Robert W. Baird | Outperform |
| Feb-28-23 | Resumed | H.C. Wainwright | Buy |
| Sep-28-22 | Initiated | SMBC Nikko | Outperform |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Apr-22-19 | Initiated | B. Riley FBR | Buy |
| Oct-28-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-27-16 | Reiterated | Maxim Group | Buy |
| Mar-11-16 | Upgrade | Maxim Group | Hold → Buy |
| Dec-16-15 | Initiated | Jefferies | Buy |
| Oct-27-15 | Downgrade | Maxim Group | Buy → Hold |
| Jul-27-15 | Reiterated | MLV & Co | Buy |
| Jun-11-15 | Initiated | Oppenheimer | Outperform |
| Jan-12-15 | Reiterated | Maxim Group | Buy |
| Jan-09-15 | Reiterated | MLV & Co | Buy |
| Jan-09-15 | Reiterated | Maxim Group | Buy |
| Dec-19-14 | Reiterated | Maxim Group | Buy |
| May-08-14 | Reiterated | Maxim Group | Buy |
| Mar-14-14 | Reiterated | MLV & Co | Buy |
| Oct-08-13 | Reiterated | Maxim Group | Buy |
| Jan-05-12 | Initiated | William Blair | Outperform |
| Dec-01-11 | Initiated | Global Hunter Securities | Buy |
View All
Agenus Inc Stock (AGEN) Latest News
Real time scanner hits for Agenus Inc. explained2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
Comparing Agenus Inc. in custom built stock radars2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Does Agenus Inc. qualify in momentum factor screeningJuly 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - Newser
Will Agenus Inc. stock recover after recent drop2025 Big Picture & Technical Confirmation Alerts - Newser
Technical signs of recovery in Agenus Inc.Fed Meeting & Weekly Momentum Picks - Newser
Detecting support and resistance levels for Agenus Inc.Earnings Summary Report & Detailed Earnings Play Alerts - Newser
Real time pattern detection on Agenus Inc. stockJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Using Python tools to backtest Agenus Inc. strategiesTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Can Agenus Inc. disrupt its industry getLinesFromResByArray error: size == 0 - thegnnews.com
Agenus Inc. stock trendline breakdownJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
How to read the order book for Agenus Inc.2025 Volatility Report & Technical Entry and Exit Tips - Newser
Historical volatility pattern of Agenus Inc. visualizedShort Setup & Smart Swing Trading Alerts - Newser
How to build a dashboard for Agenus Inc. stockQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
Shareholder Rights Advocates at Levi & Korsinsky Investigate Agenus Inc. (AGEN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing - Oncodaily
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - The Globe and Mail
Agenus Inc Stock (AGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):